Skip to content

SHIFT Trial - Family therapy vs treatment as usual for young people seen after second or subsequent episodes of self-harm

SHIFT Trial. Self-Harm Intervention, Family Therapy: a randomised controlled trial of family therapy vs treatment as usual for young people seen after second or subsequent episodes of self-harm

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN59793150
Enrollment
832
Registered
2009-01-26
Start date
2010-04-01
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-harm in adolescents Mental and Behavioural Disorders

Interventions

Participants will be individually randomised to either FT or TAU arm. FT: This will be delivered by qualified family therapists using a modified version of the Leeds Family Therapy &

Sponsors

University of Leeds (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, aged 11-17 years (from date of 11th birthday to the day prior to 18th birthday) 2. Self-harmed prior to assessment by the Child and Adolescent Mental Health (CAMHS) team 3. Engaged in at least one previous episode of self-harm prior to current presentation by self-injury or self-poisoning (or both) 4. Assessed in hospital following current episode, or referred directly to CAMHS from primary care within a week of current episode (i.e. 7 days maximum from event to referral) 5. Assessed as requiring treatment 6. Lives with primary caregiver 7. Both child/adolescent and primary caregiver have sufficient proficiency in English to participate in therapy without an interpreter 8. Both child/adolescent and primary caregiver have given written informed consent

Exclusion criteria

Exclusion criteria: 1. At serious risk of suicide 2. Severe major depressive disorder requiring psychiatric inpatient care 3. Undergoing a current child protection investigation 4. Would not ordinarily be treated in generic CAMHS but rather by a specific service (e.g., for teenage pregnancy, schizophrenia and other psychotic disorders, bipolar disorders, eating disorders [anorexia and bulimia nervosa], significant substance misuse where this is the primary diagnosis) 5. Has not been seen in CAMHS more than once in the last three months 6. In Local Authority or foster accommodation (often too transitory to allow FT) 7. Moderate to severe mental retardation or lacks capacity to comply with protocol 8. Involved in another research project - currently or within the last six months

Design outcomes

Primary

MeasureTime frame
Repetition of self-harm leading to hospital attendance within 18 months of randomisation. Admissions data will be collected from CAMHS notes and hospital records.

Secondary

MeasureTime frame
1. Repetition of self-harm leading to hospital attendance within 12 months of randomisation 2. The cost per self-harm event avoided due to FT, measured using a structured questionnaire designed for use in the trial 3. Characteristics of further episodes of self-harm (number of subsequent self-harm events, time to next event, severity of event [fatal, near fatal or not] and dangerousness of method used, as measured by the Suicide Attempt Self-Injury Interview 4. Suicidal ideation as measured by the Beck Scale for Suicide Ideation 5. Quality of life as measured by the Paediatric Quality of Life Enjoyment and Satisfaction measure, PQ-LES Mediator and moderator variables which influence engagement with and benefit from treatment will also be measured. Timepoints of assessment and other details are being finalised as of 28/01/2009.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 15, 2026